Acurx Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACXP and other ETFs, options, and stocks.

About ACXP

Acurx Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in developing new antibiotics for infections caused by bacteria listed as priority pathogens. Its approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme.

CEO

David P. Luci

CEODavid P. Luci

Employees

Employees4

Headquarters

New York, New York

HeadquartersNew York, New York

Founded

2017

Founded2017

Employees

Employees4

ACXP Key Statistics

Market cap

29.52M

Market cap29.52M

Price-Earnings ratio

-1.75

Price-Earnings ratio-1.75

Dividend yield

—

Dividend yield—

Average volume

112.10K

Average volume112.10K

High today

$2.17

High today$2.17

Low today

$1.93

Low today$1.93

Open price

$2.08

Open price$2.08

Volume

94.61K

Volume94.61K

52 Week high

$8.82

52 Week high$8.82

52 Week low

$1.17

52 Week low$1.17

Acurx Pharmaceuticals

Why Robinhood?

Acurx Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in developing new antibiotics for infections caused by bacteria listed as priority pathogens. Its approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme. Show more

ACXP Key Statistics

Acurx Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which engages in developing new antibiotics for infections caused by bacteria listed as priority pathogens. Its approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme.